Skip to content
PICO Portalanswers from OpenAlex

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects

PaperCitations, authors & open-access status

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects is a paper indexed in PICO Portal from OpenAlex.

How many citations does Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects have?

PICO Portalcitation count

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects has 20 citations in the OpenAlex counts PICO Portal stores.

When was Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects published?

PICO Portalyear

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects has 2018 year in the PICO Portal index.

What is the open-access status of Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects?

PICO Portaloa status

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects has closed oa status in the PICO Portal index.

What is the DOI of Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects?

PICO Portaldoi

The DOI for Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects is on the source record.

What is the PMID of Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects?

PICO Portalpmid

The PMID for Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects is on the source record.

What is the OpenAlex record for Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects?

PICO Portalopenalex

The OpenAlex for Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial